Nazzareno Dimasi is the Global Head of Biotherapeutics Discovery at Boehringer Ingelheim.

An accomplished leader in biologics drug discovery, Nazzareno has extensive experience in antibody discovery, antibody engineering, ADC development, and therapeutic innovation.

He leads global, multidisciplinary teams focused on advancing next-generation biotherapeutic modalities and delivering transformative medicines to patients.

He combines deep scientific expertise with strategic leadership and a proven track record of building high-performing organizations, fostering innovation, and developing talent.

Nazzareno is passionate about accelerating scientific excellence and leveraging emerging technologies to shape the future of biotherapeutics research.